July 25, 2025Open Access

Effects of CCL20/CCR6 Modulators in a T Cell Adoptive Transfer Model of Colitis

View Full Paper

Ask AI

Bookmark

CCL20 and CCR6 modulators MR120 and MR452 were tested in a T cell adoptive transfer model of colitis.
Both molecules reduced myeloperoxidase activity but did not significantly alter disease activity in colitis.
The study used immunocompromised mice receiving T cells to induce a colitis model effectively.
Results indicate the need for further exploration of CCL20/CCR6 modulation for better therapeutic outcomes in IBD.

Discussion

No takes yet. Share an insight, caveat, or question.

Adoptive transfer of T cells shows limited improvement in colitis symptoms with CCL20/CCR6 modulators, suggesting further research is needed.

Allodi et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Adoptive transfer of T cells shows limited improvement in colitis symptoms with CCL20/CCR6 modulators, suggesting further research is needed.